MONGODB, INC. (MDB)
NASDAQInformation TechnologySoftware - InfrastructureSnapshot 2026-09-04
$368.74-4.09%
Close 2026-09-04 · 1-day change
NASDAQInformation TechnologySoftware - InfrastructureSnapshot 2026-09-04
Research Workspace
Put MDB beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Systems Software is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue growth is accelerating — up about 25% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 3% on a typical day and fell roughly 49% in its worst 12-month stretch.
View RiskMongoDB's growth in Atlas revenue has to keep compounding to justify the price. The company expects Atlas growth of approximately 26% in Q3 and raised its full-year growth expectation to about 27%. It trades at 10.9× price-to-sales versus a peer median of 4.7×. The price reflects less growth than forecasted, indicating expectations look modest versus our view. A specific risk is the potential for a credibility hit if guidance is cut after a recent raise. Peer multiples imply a price about 19% below where it trades (it looks expensive on this basis). Our read remains intact.
Trailing returns as of 2026-09-04. MDB is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 42 analysts currently covering MDB (as of Sep 2026).
Based on 16 Wall Street analysts offering 12-month price targets for MDB in the last 4 months.
Continue this research
Compare MDB with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| MDB Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 9 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Systems Software — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put MDB next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Drive strong revenue growth in fiscal 2027
Earnings call indicates strong revenue growth trajectory.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $368.74
The last 12 months of price, then the range of analyst 12-month targets from today’s $368.74.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Advances: Expand AI and advanced platform capabilities
AI momentum aligns with expanding platform capabilities.
Advances: Expand AI and advanced platform capabilities
Atlas growth indicates expanding AI platform capabilities.
Threatens: Drive strong revenue growth in fiscal 2027
Earnings beat but share price decline raises growth concerns.
Advances: Quarterly revenue guidance for 2027-Q2
Surpassing estimates supports revenue growth targets.
Advances: Revenue growth target for fiscal 2027
New AI tools enhance product offering and drive revenue growth.
Advances: Revenue growth target for fiscal 2027
New capabilities align with revenue growth target.